|
|
||||||||
1Department of Veterinary Physiology, Faculty of Agriculture, and 2Department of Basic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, Gifu 501-1193; and 3Department of Oral Physiology, School of Dentistry, Meikai University, Saitama 350p-0283, Japan
Submitted 26 December 2002; accepted in final form 5 March 2003
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Although alteration in taste sensitivity and preference in VMH-lesioned
rats have been well documented at the behavioral level, possible changes in
peripheral taste nerve responsiveness accounting for the behavioral
alterations are not known. In genetically diabetic db/db mice, it has
been demonstrated that responses of the chorda tympani (CT) nerve to sugars
are greater than those of lean control mice
(Ninomiya et al. 1995
).
Recently, Kawai et al. (2000
)
showed that leptin directly suppresses the sensitivities of taste receptor
cells to sweet substances. Thus it is rational to suppose that the enhanced
responses of the CT nerve to sugars in db/db mice are due to defects
of the suppressive effect of leptin, because these mice express a mutant
leptin receptor (Chen et al.
1996
; Chua et al.
1996
; Lee et al.
1996
). VMH-lesioned rats exhibit hyperleptimia as in
db/db mice (Satoh et al.
1997
; Suga et al.
1999
,
2000
), but leptin receptors in
taste receptor cells would be unaffected by VMH destruction itself. Therefore
it is of interest whether taste nerve responsiveness to sugars is elevated or
not in VMH-lesioned rats to know the direct effects of leptin on taste-sensing
mechanism more precisely.
In the present study, we recorded responses of the CT nerves of the VMH-lesioned rats to various taste stimuli including sugars. Our results showed that the VMH-lesioned rats possess greater sensitivities to sugars except for fructose but not to other taste stimuli than control rats. Additional experiments using dietary obese and streptozotocin (STZ)-induced diabetic rats indicate that some common metabolic impairments might be related to the enhanced gustatory neural responses to sugars in addition to the direct effects of leptin.
| METHODS |
|---|
|
|
|---|
We used female Wistar rats, weighing 180230 g (67 wk old) at the time of delivery from Japan SLC (Shizuoka, Japan). They were housed individually in plastic cages at 22 ± 2°C (mean ± SD) with a 12:12-h light-dark cycle (light on 07001900 h) and given free access to laboratory chow (LABO MR Stock, Nihon-Nosan, Yokohama, Japan) and water. The rats were maintained in the laboratory for ≥2 wk after arrival to permit them to acclimate to their surroundings before experiments began (89 wk old, 250300 g at the start of experiments).
The VMH was destroyed bilaterally by an electrolytic lesion according to
the procedure described by Saito et al.
(1985
) with slight
modifications. Briefly, rats were anesthetized with pentobarbital sodium (40
mg/kg ip) and were placed in the stereotaxic instrument and positioned with
the nose bar set 5 mm above the interaural line. The electrode, consisting of
an insulated stainless steel insect pin with exposed tip, was positioned 0.6
mm lateral to the Bregma and 9.0 mm below the skull surface. A direct anodal
current of 1.2 mA for 4 s was passed through the electrode. The current pass
was repeated three times with 30-s interval. For sham controls, the same
surgical procedures were performed except that no current was passed. Only
animals that developed hyperphagia and rapid gain in body weight compared with
sham-lesioned rats were used. Sham-lesioned animals were used as controls for
possible damage to nerve fibers by the procedure. We designated the early
progressive phase of obesity as the dynamic phase (2 wk after creating VMH
lesions) and the late phase of obesity as the static phase (1518 wk
after VMH lesions). At the end of the experiments, localization of the lesions
was verified microscopically in serial frontal sections of the brain stained
with cresyl violet.
Dietary obese rats and insulin-deficient diabetic rats have been also prepared to provide a comparison with VMH-lesioned rats. To induce dietary obesity, some rats were maintained on a high-fat diet for 1820 wk. The high-fat diet contained the following (g/kg): 330 lard (Oriental Yeast, Tokyo), 50 corn oil (Oriental Yeast), 200 casein (Oriental Yeast), 225 corn starch (Oriental Yeast), 100 sucrose (Oriental Yeast), 50 cellulose (Oriental Yeast), 35 minerals (AIN76 mineral mixture; Oriental Yeast), and 10 vitamins (AIN76 vitamin mixture; Oriental Yeast). Control animals were given a standard laboratory chow (MR stock; Japan SLC, Shizuoka, Japan). Diabetic rats were made with a single-bolus intraperitoneal injection of STZ (60 mg/kg; Sigma, St. Louis, MO) dissolved in 0.1 M citric buffer (pH 4.2). The diabetic animals with fasting blood glucose concentrations of >300 mg/dl were remained untreated throughout the duration of the study.
Neural recording procedure
The CT nerve responses to various taste stimuli were recorded as previously
described (Shimizu and Tonosaki
1999
). The electrical activity of the whole CT nerve was fed to an
AC amplifier and integrated with a time constant 1.0 s. The integrated
electrical activity was led to and analyzed with PowerLab software
(ADInstruments, Mountain View, CA). The height of steady-state responses of
the integrated CT nerve activity, which were measured at 10 s after the onset
of stimuli, were normalized to means of responses to 0.1 M NH4Cl
being taken as unity (1.0). A series of taste stimulations was repeated at
least three times, and the reproducible responses were considered to be the
real responses of the respective rats.
Solutions used as chemical stimuli were (in M) 0.5 sucrose, 0.5 glucose,
0.5 fructose, 0.5 maltose, 0.05 NaCl, 0.01 HCl, 0.01 QHCl, and 0.05 monosodium
glutamate (MSG). All of the test solutions were made fresh each week and
refrigerated when not in use. The details of chemical stimulation procedures
were described previously (Ogiso et al.
2000
; Shimizu and Tonosaki
1999
).
Measurements
Blood samples were obtained after a 6-h fast (9:00 AM to 3:00 PM). Plasma glucose levels were determined by the glucose oxidase method (Glucose B-test, Wako Pure Pharmaceutical, Osaka, Japan). Plasma insulin and leptin concentrations were determined by ELISA kits (Morinaga, Yokohama, Japan).
Statistical analysis
All values were presented as means ± SE. Statistical significance was examined by an ANOVA, with post hoc testing by means of Duncan's multiple range test. Comparisons between groups were made by Student's t-test.
| RESULTS |
|---|
|
|
|---|
Figure 1 shows integrated responses of the CT nerve to various taste stimuli in sham-operated and VMH-lesioned rats. In the dynamic phase (2 wk after creating VMH lesions), there was no significant difference in the nerve responses to any taste stimulus between sham-operated and VMH-lesioned rats (Fig. 1A). In contrast, the magnitude of response to sucrose in the static phase (1518 wk after VMH lesions) was prominently greater than that in age-matched control (Fig. 1B). Magnitudes of responses to NaCl, HCl, QHCl, and MSG were unchanged even in the static phase (Fig. 1B).
|
In addition to sucrose, maltose, glucose, and fructose were also used as taste stimuli to see whether the enhancement of the CT nerve responsiveness is specific for sucrose or generalized for other sugars. As shown in Fig. 2A, the nerve responses to the four sugars were similar in both VMH-lesioned rats in the dynamic phase and their age-match sham-operated animals. In the static phase, relative magnitudes of responses to maltose and glucose, in addition to sucrose, were significantly larger than that in control animals, although no such difference was evident in response to fructose (Fig. 2B).
|
Plasma glucose, insulin, and leptin concentrations in dynamic and static phase of VMH-lesioned rats
Table 1 shows plasma glucose, insulin, and leptin concentrations in the dynamic and the static phases of VMH-lesioned rats. Plasma glucose levels did not significantly change in the dynamic phase, whereas it prominently increased in the static phase. VMH-lesioned rats in the dynamic phase had a 3-fold higher plasma insulin concentration and a 4.5-fold higher plasma leptin concentration than those in controls. These levels were further increased in the static phase. In sham-operated rats, plasma glucose and insulin levels were comparable at 2 and 1518 wk after operation, but plasma leptin levels were significantly increased during this period.
|
Chorda tympani nerve responses to various taste stimuli in diet-induced obese rats and STZ-diabetic rats
The representative recordings of the CT nerve responses to various taste stimuli from rats maintained by high-fat diet and STZ-diabetic rats are shown in Figs. 3 and 4, respectively. As was observed in VMH-lesioned obese rats, high-fat diet-induced obese rats showed greater CT nerve response to sucrose than control rats, although such a difference was not evident in response to NaCl, HCl, QHCl and MSG (Fig. 3). In STZ-diabetic rats, there was no notable change in the CT nerve responses to any stimuli used, when the nerve responses were recorded 2 wk after STZ injection (data not shown). However, in rats maintained for 4 wk after STZ injection, the magnitude of response to sucrose was specifically increased as compared with vehicle-injected control (Fig. 4).
|
|
Relative magnitudes of responses to sucrose, maltose, glucose, and fructose in diet-induced obese and STZ-induced diabetic rats were shown in Fig. 5, A and B, respectively. Similar to VMH-lesioned rats in the static phase, responses to maltose and glucose were also significantly larger than those in control animals, although no such difference was observed in response to fructose.
|
Plasma glucose, insulin, and leptin concentrations in diet-induced obese rats and STZ-diabetic rats
Table 2 represents plasma
glucose, insulin, and leptin concentrations in diet-induced obese and
STZ-induced diabetic rats. In high-fat diet fed rats, these plasma parameters
were significantly higher when compared with control rats that were maintained
on a standard diet (Table 2,
left). As expected, STZ-diabetic rats had fourfold higher plasma
glucose concentration with a marked reduction of insulin levels (
15% of
mean control values) when compared with control animals
(Table 2, right).
Plasma leptin was <0.5 ng/ml in all STZ-diabetic rats
(Table 2, right).
|
| DISCUSSION |
|---|
|
|
|---|
Recently, it has been demonstrated that taste cells express the leptin
receptor and that leptin directly increases K+ conductance,
resulting in hyperpolarization and reduction of cell excitability
(Kawai et al. 2000
).
Considering that db/db mice express a defective leptin receptor
(Chen et al. 1996
;
Chua et al. 1996
;
Lee et al. 1996
), it is
reasonable to suppose that the enhancement of CT response to sugars is due to
the lack of the suppressive effect of leptin. In accordance with this,
intraperitoneal injection of leptin to db/db mice does not affect the
CT nerve responses to sweeteners, whereas leptin substantially reduces those
in lean control animals (Kawai et al.
2000
). In the present study, we observed that the CT nerve
responses to sugars in VMH-lesioned obese rats were greater than those in
control rats. Similarly, high-fat diet-induced obese rats have greater
responses to sugars as compared with rats maintained with a standard
laboratory chow. These results conflict with the suppressive effect of leptin
on taste reactivity to sugar because plasma leptin concentration of these rats
is elevated as in db/db mice, but leptin receptors in taste cells are
intact in contrast to db/db mice. This apparent discrepancy could be
reconciled by supposing that leptin resistance is induced in taste cells. In
fact, the early progressive phase of obesity was not accompanied by changes in
CT nerve responses, suggesting that the enhancement of CT nerve responses to
sugars is established on a time scale of several months. It is generally
considered that a major mechanism for leptin resistance is a defect in the
blood-brain-barrier transport system that delivers leptin to the sites of
action in the hypothalamus (Caro et al.
1996
; Schwartz et al.
1996
; Van Heek et al.
1997
). However, in addition to the defect in leptin access, it has
been demonstrated that a signaling defect also exists in leptin-responsive
hypothalamic neurons in the mice fed high fat diet
(El-Haschimi et al. 2000
). In
addition, it has been shown recently that skeletal muscle become resistant to
the direct effects of leptin, such as increase in lipid oxidation and
triglycerol breakdown, during the development of obesity
(Steinberg and Dyck 2000
;
Steinberg et al. 2002
). It is
thus possible that the leptin signaling pathway in the taste cells is
down-regulated by prolonged hyperleptinemia in high-fat diet-induced obese
rats as well as in VMH-lesioned obese rats.
We found that STZ-induced diabetic rats have higher CT nerve responses to
sugars as in VMH-lesioned obese rats. This result seems to conflict with that
reported by Ninomiya et al.
(1995
), who have demonstrated
that STZ-induced diabetic mice show no significant difference in CT nerve
responses to sugars compared with the control mice. This difference is
probably derived from the difference in duration of diabetic state. In fact,
we failed to observe significant changes in CT nerve responses to sugars 2 wk
after STZ injection, whereas the enhancement of sugar responses of CT became
evident after 4 wk of STZ injection. It should be noted, however, that the
plasma leptin was reduced much by 2 wk after STZ injection
(Table 2)
(Havel et al. 1998
). If leptin
exerts a tonic inhibitory effect on sweet taste sensing mechanism in taste
cells under the normal conditions, the reduction of circulating leptin may
result in an increased sensitivity of taste cells immediately. The evidence
that the time course of increase in CT responses to sugars does not coincide
with a reduction of serum leptin level suggests that some chronic factors,
including lowered leptin levels, alters the taste-sensing mechanism under the
diabetic and obese conditions.
At present, the putative chronic factors that affect the sugar-sensing
system in taste cells are not known. We speculate, however, that a chronic
increase in plasma glucose and reduction of insulin action are likely to
underlie the altered sensitivity of CT responses to sugars. Under the diabetic
condition, tissue glucose utilization may be limited because of insulin
deficiency or insulin resistance. Furthermore, persistent hyperglycemia has
been known to reduce the brain blood flow and the glucose transport across the
blood-brain barrier (Gjedde and Crone
1981
; Harik and LaManna
1988
; Matthaei et al.
1986
; Pardridge et al.
1990
), both of which would result in a lowered supply of glucose
to the brain. Thus these conditions can be recognized as an insufficiency of
intracellular glucose, in spite of the presence of excess extracellular
glucose. Considering that enhancement of sugar responsiveness of CT is
correlated with an increase in sugar intake behavior (Ninomiya et al.
1995
,
2002
), the enhancement of CT
nerve responses to sugars in diabetic rats is inferred to be an adaptive
change to satisfy the demand for glucose of brain and peripheral tissues. In
accordance with this, we found that VMH-lesioned obese rats showed a strong
preference for starch, which is a source of glucose but possesses different
taste quality than sugars (Y. Shimizu, T. Takewaki, and K. Tonosaki,
unpublished observation).
One of the characteristics observed commonly among VMH-lesioned obese rats,
high-fat diet-induced obese rats and STZ-diabetic rats is that CT nerve
responses to fructose were unchanged in contrast to those to glucose, sucrose,
and maltose. Several lines of evidences have suggested that there are multiple
receptor sites for sugars in taste cells
(Beidler and Tonosaki 1985
;
Jakinovich 1976
;
Jakinovich and Goldstein 1976
;
Tonosaki and Funakoshi 1984
,
1989
). Recently, receptors for
sweet taste stimuli including sugars were identified as T1Rs
(Li et al. 2002
;
Margolskee 2002
;
Nelson et al. 2001
). However,
in contrast to bitter taste receptors T2Rs that constitute a large multigene
family (Adler et al. 2000
;
Chandrashekar et al. 2000
;
Matsunami et al. 2000
), T1Rs
family is small and the only one form of functional sweet receptor is known to
be a heterodimer of T1R2 and T1R3 (Li et
al. 2002
; Nelson et al.
2001
). Available data have suggested that the heterodimer of T1R2
and T1R3 can be activated by most of sweet-tasting substances including
fructose, glucose, sucrose, and maltose
(Li et al. 2002
). Thus the
molecular basis for the multiple receptor sites for sugars is not so far
established. Since several G protein
-subunits have been identified in
taste receptor cells (Kusakabe et al.
1998
; McLaughlin et al.
1992
; Ruiz-Avila et al.
1995
), it is possible that coupling patterns of the T1Rs and G
proteins is related to the sweet taste specificity. In fact, co-expression
experiments of T1R2/T1R3 complex with various G
15 chimeras in which the
five-residue C-terminal tail was replaced by those of other G proteins showed
that sucrose induced an increase in intracellular calcium when some specific
chimeras were present (Li et al.
2002
). Although the precise mechanism for the fructose-sensing
system is not clear, it may be separate from other sugar receptors, and the
factors that promote enhancement of responsiveness for glucose, sucrose, and
maltose are ineffective for this putative fructose-sensing mechanism. In
support of this notion, it has been reported that preabsorptive recognition of
fructose and glucose in small intestine is made in a different manners (Mei
1978
,
1985
).
Physiological significance of the differences of the responses between
fructose and other sugars are not known. It has been demonstrated that
fructose ingestion induces insulin resistance and hyperlipidemia in rats
(Elliott et al. 2002
). This
disadvantage of fructose as an energy source may be related to the lack of
adaptive changes in taste sensing system for fructose. In accordance with
this, our preliminary experiments with two-bottle preference tests (glucose
vs. fructose) show that the relative preference of glucose solution was
increased day by day, and the rats become to drink glucose solution
exclusively within a week (Y. Shimizu, T. Takewaki, and K. Tonosaki,
unpublished observation).
One of the striking characteristics of VMH-lesioned rats is their
hyperreactivity to QHCl adulterated in foods
(Corbit and Stellar 1964
; Graff
and Stelilar 1962; Weingarten
1982
). We failed to detect changes in CT nerve responses to QHCl
in VMH-lesioned rats. It should be mentioned, however, that changes in
ingestive behavior are not necessarily accompanied by the corresponding
changes in taste nerve reactivity. Accordingly, it seems likely that
hyperreactive behavior to QHCl in VMH-lesioned rats depends on the
differential responsiveness of higher centers that receive taste information.
Further study is needed to establish the neurophysiological bases for
finickiness of VMH-lesioned obese rats.
In summary, the present study shows that the responsiveness of the CT nerve to sugars is enhanced during the development of diabetes and obesity. Although leptin is established as an important regulator of the sweet-taste-sensing system, our results have suggested that some chronic factors, including high blood glucose, inefficiency of insulin action, or leptin resistance may be related to the enhancement of CT nerve responses to sugars.
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
Address for reprint requests: Correspondence to be sent to: Prof. Tadashi Takewaki, Department of Veterinary Physiology, Faculty of Agriculture, Gifu University, Gifu 501-1193, Japan Tel: (81)58293-2940 Fax: (81)58293-2940 E mail: tt{at}cc.gifu-u.ac.jp
| REFERENCES |
|---|
|
|
|---|
Beidler LM and Tonosaki K. Multiple sweet receptor sites and taste theory. In: Taste, Olfaction, and the Central Nervous System, edited by Pfaff DW. New York: The Rockefeller University Press, 1985, p. 4764.
Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, and Considine RV. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348: 159161, 1996.[ISI][Medline]
Chandrashekar J, Mueller KL, Hoon MA, Adler E, Feng L, Guo W, Zuker CS, and Ryba NJ. T2Rs function as bitter taste receptors. Cell 100: 703711, 2000.[ISI][Medline]
Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, and Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491495, 1996.[ISI][Medline]
Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, and Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271: 994996, 1996.[Abstract]
Corbit JD and Stellar E. Palatability, food intake, and obesity in normal and hyperphagic rats. J Comp Physiol Psychol 58: 6367, 1964.[ISI][Medline]
Elliott SS,
Keim NL, Stern JS, Teff K, and Havel PJ. Fructose, weight gain, and the
insulin resistance syndrome. Am J Clin Nutr
76: 911922,
2002.
El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, and Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105: 18271832, 2000.[ISI][Medline]
Gjedde A and
Crone C. Blood-brain glucose transfer: repression in chronic
hyperglycemia. Science 214:
456457, 1981.
Graff H and Stellar E. Hyperphagia, obesity, and finickiness. J Comp Physiol Psychol 55: 418424, 1962.[ISI][Medline]
Harik SI and LaManna JC. Vascular perfusion and blood-brain glucose transport in acute and chronic hyperglycemia. J Neurochem 51: 19241929, 1988.[ISI][Medline]
Havel PJ,
Uriu-Hare JY, Liu T, Stanhope KL, Stern JS, Keen CL, and Ahren B.
Marked and rapid decreases of circulating leptin in streptozotocin diabetic
rats: reversal by insulin. Am J Physiol Regulatory Integrative Comp
Physiol 274:
R1482R1491, 1998.
Jakinovich W Jr. Stimulation of the gerbil's gustatory receptors by disaccharides. Brain Res 110: 481490, 1976.[ISI][Medline]
Jakinovich W Jr and Goldstein IJ. Stimulation of the gerbil's gustatory receptors by monosaccharides. Brain Res 110: 491504, 1976.[ISI][Medline]
Kawai K,
Sugimoto K, Nakashima K, Miura H, and Ninomiya Y. Leptin as a modulator of
sweet taste sensitivities in mice. Proc Natl Acad Sci
USA 97:
1104411049, 2000.
Kusakabe Y, Yamaguchi E, Tanemura K, Kameyama K, Chiba N, Arai S, Emori Y, and Abe K. Identification of two alpha-subunit species of GTP-binding proteins, Galpha15 and Galphaq, expressed in rat taste buds. Biochim Biophys Acta 1403: 265272, 1998.[Medline]
Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, and Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632635, 1996.[Medline]
Li X,
Staszewski L, Xu H, Durick K, Zoller M, and Adler E. Human receptors for
sweet and umami taste. Proc Natl Acad Sci USA
99: 46924696,
2002.
McLaughlin SK, McKinnon PJ, and Margolskee RF. Gustducin is a taste-cell-specific G protein closely related to the transducins. Nature 357: 563569, 1992.[Medline]
Margolskee RF. Molecular mechanisms of bitter and sweet
taste transduction. J Biol Chem
277: 14,
2002.
Matsunami H, Montmayeur JP, and Buck LB. A family of candidate taste receptors in human and mouse. Nature 404: 601604, 2000.[Medline]
Matthaei S, Horuk R, and Olefsky JM. Blood-brain glucose transfer in diabetes mellitus. Decreased number of glucose transporters at blood-brain barrier. Diabetes 35: 11811184, 1986.[Abstract]
Mei N.
Vagal glucoreceptors in the small intestine of the cat. J
Physiol 282:
485506, 1978.
Mei N.
Intestinal chemosensitivity. Physiol Rev
65: 211237,
1985.
Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, and Zuker CS. Mammalian sweet taste receptors. Cell 106: 381390, 2001.[ISI][Medline]
Ninomiya Y,
Sako N, and Imai Y. Enhanced gustatory neural responses to sugars in the
diabetic db/db mouse. Am J Physiol Regulatory Integrative Comp
Physiol 269:
R930R937, 1995.
Ninomiya Y, Shigemura N, Yasumatsu K, Ohta R, Sugimoto K, Nakashima K, and Lindemann B. Leptin and sweet taste. Vitam Horm 64: 221248, 2002.[ISI][Medline]
Ogiso K,
Shimizu Y, Watanabe K, and Tonosaki K. Possible involvement of
undissociated acid molecules in the acid response of the chorda tympani nerve
of the rat. J Neurophysiol 83:
27762779, 2000.
Pardridge WM, Triguero D, and Farrell CR. Downregulation of blood-brain barrier glucose transporter in experimental diabetes. Diabetes 39: 10401044, 1990.[Abstract]
Ruiz-Avila L, McLaughlin SK, Wildman D, McKinnon PJ, Robichon A, Spickofsky N, and Margolskee RF. Coupling of bitter receptor to phosphodiesterase through transducin in taste receptor cells. Nature 376: 8085, 1995.[Medline]
Saito M,
Minokoshi Y, and Shimazu T. Brown adipose tissue after ventromedial
hypothalamic lesions in rats. Am J Physiol Endocrinol
Metab 248:
E20E25, 1985.
Satoh N, Ogawa
Y, Katsuura G, Tsuji T, Masuzaki H, Hiraoka J, Okazaki T, Tamaki M,
Hayase M, Yoshimasa Y, Nishi S, Hosoda K, and Nakao K. Pathophysiological
significance of the obese gene product, leptin, in ventromedial hypothalamus
(VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned
rats. Endocrinology 138:
947954, 1997.
Schwartz MW, Peskind E, Raskind M, Boyko EJ, and Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2: 589593, 1996.[ISI][Medline]
Shimizu Y and
Tonosaki K. Low environmental temperature modulates gustatory nerve
activity and behavioral responses to NaCl in rats. Am J Physiol
Regulatory Integrative Comp Physiol 277:
R368R373, 1999.
Steinberg GR and Dyck DJ. Development of leptin resistance in rat soleus muscle in
response to high-fat diets. Am J Physiol Endocrinol
Metab 279:
E1374E1382, 2000.
Steinberg GR,
Parolin ML, Heigenhauser GJ, and Dyck DJ. Leptin increases FA oxidation in
lean but not obese human skeletal muscle: evidence of peripheral leptin
resistance. Am J Physiol Endocrinol Metab
283: E187E192,
2002.
Suga A, Hirano T, Inoue S, Tsuji M, Osaka T, Namba Y, Miura M, and Adachi M. Plasma leptin levels and triglyceride secretion rates in VMH-lesioned obese rats: a role of adiposity. Am J Physiol Endocrinol Metab E650E657, 1999.
Suga A, Hirano
T, Kageyama H, Osaka T, Namba Y, Tsuji M, Miura M, Adachi M, and Inoue
S. Effects of fructose and glucose on plasma leptin, insulin, and insulin
resistance in lean and VMH-lesioned obese rats. Am J Physiol
Endocrinol Metab 278:
E677E683, 2000.
Tonosaki K and Funakoshi M. The mouse taste cell response to five sugar stimuli. Comp Biochem Physiol 79A: 625630, 1984.
Tonosaki K and Funakoshi M. Cross-adapted sugar responses in the mouse taste cell. Comp Biochem Physiol 92A: 181183, 1989.
Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, and Davis HR Jr. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 99: 385390, 1997.[ISI][Medline]
Weingarten HP. Diet palatability modulates sham feeding in VMH-lesion and normal rats: inplications for finickiness and evaluation of sham-feeding data. J Comp Physiol Psychol 96: 223233, 1982.[ISI][Medline]
This article has been cited by other articles:
![]() |
A. Hajnal, N. K. Acharya, P. S. Grigson, M. Covasa, and R. C. Twining Obese OLETF rats exhibit increased operant performance for palatable sucrose solutions and differential sensitivity to D2 receptor antagonism Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R1846 - R1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hajnal, M. Covasa, and N. T. Bello Altered taste sensitivity in obese, prediabetic OLETF rats lacking CCK-1 receptors Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1675 - R1686. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |